Molecular and cellular aspects of the glucagon receptor: Role in diabetes and metabolism

Diabetes and Metabolism

Volumn 22, Issue 6, 1996, Pages 373-396

  Burcelin, R ^a,d   Katz, E B ^a   Charron, M J ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b AMERICAN DIABETES ASSOCIATION   (United States)

^c PEW CHARITABLE TRUSTS   (United States)

^d Philippe Foundation   (France)

Author keywords

gene cloning liver; glucose production; GTP binding protein coupled receptor; seven transmembrane domain receptor

Indexed keywords

GLUCAGON; GLUCAGON RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; METABOLISM; RECEPTOR GENE; REVIEW;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; BRAIN; CARDIOVASCULAR PHYSIOLOGY; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; DIABETES MELLITUS; GLUCAGON; GTP-BINDING PROTEINS; HUMANS; ISLETS OF LANGERHANS; KIDNEY; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN CONFORMATION; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 0029840285     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (267)

1. Bernard C. Leçons sur le diabète et la glycogénèse animal : Baillère, Paris, 1877.
2. Unger H. Glucagon physiology and pathophysiology in the light of new advances. [Review]. Diabetologia, 1985, 28, 574-578.
3. Unger H. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. [Review]. Metabolism: Clinical & Experimental, 1978, 27, 1691-1709.
4. Unger H, Orci L. Glucagon and the A cell : physiology and pathophysiology (first two parts). N Engl J Med, 1981, 304, 1518-1524.
5. Unger H, Orci L. The role of glucagon in diabetes. Comprehensive Therapy, 1982, 8, 53-59.
6. Kervran, Blache P, Bataille D. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology, 1987, 121, 704-713.
7. Bataille, Freychet P, Rosselin G. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes : binding to specific sites and stimulation of adenylate cyclase. Endocrinology, 1974, 95, 713-721.
8. Hatton W, Kovacevic N, Dutczak M, Vranic M. Glucagon-like immunoreactants in extracts of the rat hypothalamus. Endocrinology, 1982, 111, 572-577.
9. Jin L, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytocheminal study. Journal of Comparative Neurology, 1988, 271, 519-532.
10. Han K, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. Journal of Neuroscience Research, 1986, 16, 97-107.
11. Dorn, Rinne A, Bernstein HG, Hahn HJ, Ziegler M, Dammert K. Immunoreactive glucagon in neurons of various parts of the human brain. Demonstration by immunofluorescence technique. Acta Histochemica, 1981, 69, 243-247.
12. Sperling A, Ganguli S, Leslie N, Landt K. Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. Am J Physiol, 1984, 247, 69-74.
13. Eliot J, Lam R, Leake RD, Hobel CJ, Fisher DA. Plasma catecholamine concentrations in infants at birth and during the first 48 hours of life. Journal of Pediatrics, 1980, 96, 311-315.
14. Girard R, Kervran A, Soufflet E, Assan R. Factors affecting the secretion of insulin and glucagon by the rat fetus. Diabete, 1974, 23, 310-317.
15. Girard. Metabolic adaptations to change of nutrition a birth. [Review]. Biology of the Neonate, 1990, 1, 3-15.
16. Girard. Gluconeogenesis in late fetal and early neonatal life. [Review]. Biology of the Neonate, 1986, 50, 237-258.
17. Perdereau, Narkewicz M, Coupe C, Ferre P, Girard J. Hormonal control of specific gene expression in the rat liver during the suckling-weaning transition. Advances in Enzyme Regulation, 1990, 30, 91-108.
18. Pegorier P, Duee PH, Assan R, Peret J, Girard J. Changes in circulating fuels, pancreatic hormones and liver glycogen concentration in fasting or suckling newborn pigs. Journal of Developmental Physiology, 1981, 3, 203-217.
19. Ferre, Decaux JF, Issad T, Girard J. Changes in energy metabolism during the suckling and weaning period in the newborn. [Review]. Reproduction, Nutrition, Developpement, 1986, 26, 619-631.
20. Iyengar, Herberg JT. Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region. J Biol Chem, 1984, 259, 5222-5229.
21. Serge V, Goldring SR. Receptor for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone and glucagon belong to a newly discovered G-binding-linked receptor family. Trends in Endocrinology and Metabolism, 1993, 4, 309-314.
22. Ishibara, Nakamura S, Kaziro Y, Takahashi T, Takahashi K, Nagata S. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J, 1991, 10, 1635-1641.
23. Ishibara, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuon, 1992, 8, 811-819.
24. Lin Y, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF, Jr, Yamin M, Lodish HF, Goldring SR. Expression cloning and characterization of a porcine renal calcitonin receptor. Transactions of the Association of American Physicians, 1991, 104, 265-272.
25. Lin Y, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF, Jr, Lodish HF and Goldring SR. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science, 1991, 254, 1022-1024.
26. Mayo E, Vale W, Rivier J, Rosenfeld MG, Evans RM. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature, 1983, 306, 86-88.
27. Thorens. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA, 1992, 89, 8641-8645.
28. Birnbaumer, Pohl SL, Rodbell M, Sundby F. The glucagon-sensitive adenylate cyclase system in plasma membranes of rat liver. VII. Hormonal stimulation: reversibility and dependence on concentration of tree hormone. J Biol Chem, 1972, 247, 2038-2043.
29. Lin C, Salomon Y, Rendell M, Rodbell M. The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH. J Biol Chem, 1975, 250, 4246-4252.
30. Rendell, Salomon Y, Lin MC, Rodbell M, Berman M. The hepatic adenylate cyclase system. III. A mathematical model for the steady state kinetics of catalysis and nucleotide regulation. J Biol Chem. 1975, 250, 4253-4260.
31. Salomon, Lin MC, Londos C, Rendell M, Rodbell M. The hepatic adenylate cyclase system. I. Evidence for transition states and structural requirements for guanine nucleotide activation. J Biol Chem, 1975, 250 4239-4245.
32. Rodbell. The actions of hormones an adenylate cyclase systems. National Cancer Institute Monographs, 1978, 48, 271-276.
33. Lok, Kuijper JL, Jelinek LJ, Kramer JM, Whitmore TE, Sprecher CA, Mathewes S, Grant FI, Biggs SH, Rosenberg GB et al. The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. Gene, 1994, 140, 203-209.
34. Wakelam J, Murphy GJ, Hruby VJ, Houslay MD. Activation of two signal-transduction systems in hepatocyptes by glucagon. Nature, 1986, 323, 68-71.
35. Unson G, Gurzenda EM, Merrifield RB. Biological activities of des-His 1 [Glu 9] glucagon amide, a glucagon antagonist. Peptides, 1989, 10, 1171-1177.
36. Blache, Kervran A, Dufour M, Martinez J, Le-Nguyen D, Lotersztajn S, Pavoine C, Pecker F, Bataille D. Glucagon-(19-29), a Ca2 + pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. J Biol Chem, 1990, 265, 21514-21519.
37. Gehnrich C, Gekakis N, Sul S. Liver (B-type) phosphofructokinase mRNA. Cloning, structure, and expression. J Biol Chem, 1988, 263, 11755-11759.
38. Volz, Goke R, Lankat-Buttgereit B, Fehmann HC, Bode HP, Goke B. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. FEBS Letters, 1995, 373, 23-29.
39. Rodbell, Birnbaumer L, Pohl SL, Sundby F. The reaction of glucagon with its receptor : evidence for discrete regions of activity and binding in the glucagon molecule. Proc Natl Acad Sci USA, 1971, 68, 909-913.
40. Bregman D, Cheng S, Levy D. Synthesis and properties of a photoaffinity probe for the glucagon receptor in hepatocyte plasma membranes. Biochim Biophys Acta, 1978, 539, 489-495.
41. Herberg T, Codina J, Rich KA, Rojas FJ, Iyengar R. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. J Biol Chem, 1984, 259, 9285-9294.
42. Iyengar, Herberg JT, Rich KA. Characterization of the hepatic glucagon receptor. Journal of Receptor Research, 1984, 4, 247-265.
43. Butlen, Morel F. Glucagon receptors along the nephron : [125I] glucagon binding in rat tubules. Pflugers Archiv European Journal of Physiology. 1985, 404, 348-353.
44. Bailly, Imbert-Teboul M, Chabardes D, Hus-Citharel A, Montegut M, Clique A, Morel F. The distal nephron of rat kidney : a target site for glucagon. Proc Natl Acad Sci USA, 1980, 77, 3422-3424.
45. Ahloulay, Dechaux M, Laborde K, Bankir L. Influence of glucagon on GFR and urea and on electrolyte excretion: direct and indirect effects. Am J Physiol. 1995, 269, F225-235.
46. Ahloulay, Bouby N, Machet F, Kubrusly M, Coutaud C, Bankir L. Effects of glucagon on glomerular filtration rate and urea and water excretion. Am J Physiol, 1992, 263, F24-36.
47. Santamaria, de Miguel E, Codesal J, Ramirez JR, Picazo J. Identification of glucagon binding sites on smooth muscle tissue of dog intestine. Quantification by means of ultrastructural autoradiography. Anatomischer Anzeiger, 1991, 172, 149-157.
48. Kofod, Unson CG, Merrifield RB. Potentiation of glucose-induced insulin release in islets by desHis 1 [Glu 9] glucagon amide. International Journal of Peptide & Protein Research, 1988, 32, 436-440.
49. Hoosein M, Gurd RS. Identification of glucagon receptors in rat brain. Proc Natl Acad Sci USA, 1984, 81, 4368-4372.
50. Sonne, Gliemann J. Receptor binding of glucagon and adenosine 3′, 5′-monophosphate accumulation in isolated rat fat cells. Biochim Biophys Acta, 1977, 499, 259-272.
51. Desbuquois, Baudat MH. Glucagon-receptor interactions in fat cell membranes. Mol Cell Endocrinol, 1974, 1, 355-370.
52. Pilkis J, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. [Review]. Annu Rev Physiol, 1992, 54, 885-909.
53. Rodbell, Birnbaumer L, Pohl SL. Characteristics of glucagon action on the hepatic adenylate cyclase system. Biochem J, 1971, 125, 58P-59P.
54. Murphy J, Hruby VJ, Trivedi D, Wakelam MJ, Houslay MD. The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phosphokipid metabolism. Biochem J, 1987, 243, 39-46.
55. Savage, Zeng L, Houslay MD. A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes. Biochem J, 1995, 307, 281-285.
56. Rozwadowski, Stephen LL, Goss PM, Bray TM, Nagy LE. Activity of cAMP-dependent protein kinase is reduced in protein-energy malnourished rats. Journal of Nutrition, 1995, 125, 401-409.
57. Pilkis J, Chrisman T, Burgress B, McGrane M, Colosia A, Pilkis J, Claus TH, el-Maghrabi MR. Rat hepatic 6-phosphofructo 2-kinase/fructose, 2,6-bisphosphatase: a unique bifunctional enzyme. Advances in Enzyme Regulation, 1983, 21, 147-173.
58. Claus H, Schlumpf J, Maghrabi MR, McGrane M, Pilkis SJ. Glucagon stimulation of fructose 1,6-bisphosphatase phosphorylation in rat hepatocytes. Biochem Biophys Res Commun, 1981, 100, 716-723.
59. el-Maghrabi R, Claus TH, Pilkis J, Pilkis SJ. Regulation of 6-phosphofructo-2-kinase acitvity by cyclic AMP-dependent phosphorylation. Proc Natl Acad Sci USA, 1982, 79, 315-319.
60. Claus H, Schlumpf JR, el-Maghrabi MR, Pilkis J, Pilkis SJ. Mechanism of action of glucagon on hepatocyte phosphofructokinase activity. Proc Natl Acad Sci USA, 1980, 77, 6501-6505.
61. Iynedjian B, Hanson RW. Regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in the kidney. Current Problems in Clinical Biochemistry, 1977, 8, 299-309.
62. Iynedjian B, Salavert A. Effects of glucagon, dexamethasone and triiodothyronine on phosphoenolpyruvate carboxykinase (GTP) synthesis and mRNA level in rat liver cells. Eur J Biochem, 1984, 145, 489-497.
63. Salavert, Inedjian PB. Regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat liver cells. Rapid induction of specific mRNA by glucagon or cyclic AMP and permissive effect of dexamethasone. J Biol Chem, 1982, 257, 13404-13412.
64. el-Maghrabi R, Lange AJ, Kummel L, Pilkis SJ. The rat fructose-1,6-bisphosphatase gene. Structure and regulation of expression. J Biol Chem, 1991, 206, 2115-2120.
65. el-Maghrabi R, Gidh-Jain M, Austin LR, Pilkis SJ. Isolation of a human liver fructose-1,6-bisphosphatase cDNA and expression of the protein in Escherichia coli. Role of ASP-118 and ASP-121 in catalysis. J Biol Chem, 1993, 268, 9466-9472.
66. Marker J, Colosia AD, Tauler A, Solomon DH, Cayre Y, Lange AJ, el-Maghrabi MR, Pilkis SJ. Glucocorticoid regulation of hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene expression. J Biol Chem, 1989, 264, 7000-7004.
67. Tauler, Lange AJ, el-Maghrabi MR, Pilkis SJ. Expression of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and its kinase domain in Escherichia coli. Proc Natl Acad Sci USA, 1989, 86, 7316-7320.
68. Espinet, Vargas AM, el-Maghrabi MR, Lange AJ, Pilkis SJ. Expression of the liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA in FAO-1 cells. Biochem J. 1993, 293, 173-179.
69. Haber A, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest, 1995, 95, 832-841.
70. Minassian, Daniele N, Bordet JC, Zitoun C, Milhieux G. Liver glucose-6 phosphatase activity is inhibited by refeeding in rats. Journal of Nutrition, 1995, 125, 2727-2732.
71. Printz L, Magnuson MA, Granner DK. Mammalian glucokinase. [Review]. Annual Review of Nutrition, 1993, 13, 463-496.
72. Girard, Perdereau D, Narkewicz M, Coupe C, Ferre P, Decaux JF, Bossard P. Hormonal regulation of liver phosphoenolpyruvate carboxykinase and glucokinase gene expression at weaning in the rat. [Review]. Biochimie, 1991, 73, 71-76.
73. Decaux F, Antoine B, Kahn A. Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem, 1989, 264, 11584-11590.
74. Raymondjean, Vaulont S, Cognet M, Decaux JF, Puzenat N, Bergot MO, Kahn A. Positive and negative regulation of gene expression by insulin and glucagon : the model of L-type pyruvate kinase gene. [Review]. Biochimie, 1991, 73, 41-45.
75. Hod, Hanson RW. Cyclic AMP stabilizes the mRNA for phosphoenolpyruvate carboxykinase (GTP) against degradation. J Biol Chem. 1988, 263, 7747-7752.
76. Alberti G, Johnston DG, Gill A, Barnes AJ, Orskov H. Hormonal regulation of ketone-body metabolism in man. Biochemical Society Symposia, 1978, 43, 163-182.
77. Gonzalez-Manchon, Ayuso MS, Parrilla R. Control of hepatic gluconeogenesis : role of fatty acid oxidation. Archives of Biochemistry & Biophysics, 1989, 271, 1-9.
78. McGarry D, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. [Review]. Annual Review of Biochemistry, 1980, 49, 395-420.
79. Pegorier P, Prip-Buus C, Duee PH, Girard J. Hormonal control of fatty acid oxidation during the neonatal period. [Review]. Diabetes & Metabolism, 1992, 18, 156-160.
80. Pegorier P, Garcia-Garcia MV, Prip-Buus C, Duee PH, Kohl C, Girard J. Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment. Biochem J, 1989, 264, 93-100.
81. Zammit A. Regulation of hepatic fatty acid oxidation and ketogenesis. [Review]. Proceedings of the Nutrition society, 1983, 42, 289-302.
82. McGarry D, Foster DW. Importance of experimental conditions in evaluating the malonyl-CoA sensitivity of liver carnitine acyltransferase. Studies with fed and starved rats. Biochem J, 1981, 200, 217-223.
83. Prip-Buus, Pegorier JP, Duee PH, Kohl C, Girard J. Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes. Biochem J, 1990, 269, 409-415.
84. McGarry D. Disordered metabolism in diabetes : have we underemphasized the fat component? [Review]. Journal of Cellular Biochemistry, 1994, 55, 29-38.
85. Vilstrup, Hansen BA, Almdal TP. Glucagon increases hepatic efficacy for urea synthesis. Journal of Hepatology, 1990, 10, 46-50.
86. Flakoll J, Borel MJ, Wentzel LS, Williams PE, Lacy DB, Abumrad NN. The role of glucagon in the control of protein and amino acid metabolism in vivo. Metabolism: Clinical & Experimental, 1994, 43, 1509-1516.
87. Svoboda, Tastenoy M, Vertongen P, Robberecht P. Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol, 1994, 105, 131-137.
88. Campos V, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology, 1994, 134, 2156-2164.
89. Burcelin, Li J, Charron MJ. Cloning and sequence analysis of the murine glucagon receptor-encoding gene. Gene, 1995, 164, 305-310.
90. Montaron, Moyse E, Barre H. Radioautographic demonstration and localization of glucagon receptors in duck brain. Brain Research, 1994, 663, 121-130.
91. Heckemeyer M, Barker J, Duckworth WC, Solomon SS. Studies of the biological effect and degradation of glucagon in the rat perifused isolated adipose cell. Endocrinology, 1983, 113, 270-276.
92. Carpentier L, Perrelet A, Orci L. Effects of insulin, glucagon, and epinephrine on the plasma membrane of the white adipose cell : a freeze-fracture study. Journal of Lipid Research, 1976, 17, 335-442.
93. Rubin S, Lai E, Rosen OM. Acquisition of increased hormone sensitivity during in vitro adipocyte development. J Biol Chem, 1977, 252, 3554-3557.
94. Oscar P. Glucagon binding to receptors on the surface of chicken adipocytes. Journal of Animal Science, 1995, 73, 728-737.
95. Chohan, Saggerson D. Increased sensitivity of adipocyte adenylate cyclase to glucagon in the fasted state. FEBS Letters, 1982, 146, 357-360.
96. Palmer M, Taberner PV, Houslay MD. Alterations in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity. Cellular Signalling, 1992, 4, 365-377.
97. Jensen D, Heiling VJ, Miles JM. Effects of glucagon on free fatty acid metabolism in humans. Journal of Clinical Endocrinology & Metabolism, 1991, 72, 308-315.
98. Saggerson D. Sensitivity of adipocyle lipolysis to stimulatory and inhibitory agonists in hypothyroidism and starvation. Biochem J, 1986, 238, 387-394.
99. Fernandez M, Saggerson ED. Alterations in response of rat white adipocytes to insulin, noradrenaline, corticotropin and glucagon after adrenalectomy. Correction of these changes by adenosine deaminase. Biochem J, 1978, 174, 111-118.
100. Lorenzo, Roncero C, Fabregat I, Benito M. Hormonal regulation of rat foetal lipogenesis in brown-adipocyte primary cultures. Biochem J, 1988, 251, 617-620.
101. Slavin G, Ong JM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. Journal of Lipid Research, 1994, 35, 1535-1541.
102. Doi, Kuroshima A. Thermogenic response to glucagon in cold-acclimated mice. Japanese Journal of Physiology, 1982, 32, 377-385.
103. Uehara, Habara Y, Kuroshima A. Effect of cold acclimation on glucagon receptors of rat white adipocytes. Japanese Journal of Physiology, 1986, 36, 891-903.
104. Yahata, Kuroshima A. Cold-induced changes in glucagon of brown adipose tissue. Japanese Journal of Physiology, 1987, 37, 773-782.
105. Ogawa, Ohno T, Kuroshima A. Effects of cold acclimation on cold-induced changes in lipid metabolism of rat brown adipose tissue. Japanese Journal of Physiology, 1992, 42, 63-73.
106. Yahata, Ohno T, Kuroshima A. Improved cold tolerance in glucagon-treated rats. Life Sciences, 1981, 28, 2603-2610.
107. Habara, Kuroshima A. Changes in glucagon and insulin contents of brown adipose tissue after temperature acclimation in rats. Japanese Journal of Physiology, 1983, 33, 661-665.
108. Kuroshima, Yahata T, Ohno T. Changes in plasma glucagon levels to stressful environmental temperatures. Japanese Journal of Physiology, 1981, 31, 43-52.
109. Kuroshima, Yahata T. Noradrenaline-induced changes in rat brown adipose tissue glucagon. Japanese Journal of Physiology, 1989, 39, 311-315.
110. Kikuchi, Okano S, Nozu T, Yahata T, Kuroshima A. Effects of chronic administration of noradrenaline and glucagon on in vitro brown adipose tissue thermogenesis. Japanese Journal of Physiology, 1992, 42, 165-170.
111. Desbuquois, Authier F. [Glucagon receptors]. [French]. Annales d'Endocrinologie, 1989, 50, 440-446.
112. Madsen N, Sonne O. Increase of glucagon receptors in hyperthyroidism. Nature, 1976, 262, 793-795.
113. Perea, Clemente F, Martinell J, Villanueva-Penacarrillo ML, Valverde I. Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res, 1995, 27, 372-375.
114. Kitabgi, Rosselin G, Bataille D. Interactions of glucagon and related peptides with chicken adipose tissue. Horm Metab Res, 1976, 8, 266-270.
115. Carlson G, Snead WL, Campbell PJ. Regulation of free fatty acid metabolism by glucagon [see comments|. Journal of Clinical Endocrinology & Metabolism, 1993, 77, 11-15.
116. Watanabe, Irie M, Kajinuma H, Suzuki K. Adrenalectomy-induced alterations in glucagon binding and lipolysis in isolated rat adipocytes. Horm Metab Res, 1990, 22, 215-220.
117. Yamauchi, Hashizume K. Glucagon alters insulin binding to isolated rat epididymal adipocytes: possible role of adenosine 3′, 5′-monophosphate in modification of insulin action. Endocrinology, 1986, 119, 218-223.
118. Yamauchi, Hashizume K, Miyamoto T, Otsuka H, Ichikawa K, Nishii Y, Yamada T. Selective alterations of insulin actions by glucagon in isolated rat epididymal adipocytes. Endocrinology, 1988, 123, 2800-2804.
119. Hashizume, Yamauchi K. Effect of insulin on glucagon binding to isolated rat epididymal adipocytes. Biochem Biophys Res Commun, 1986, 141, 812-817.
120. Green. Glucagon inhibition of insulin-stimulated 2-deoxyglucose uptake by rat adipocytes in the presence of adenosine deaminase. Biochem J. 1983, 212, 189-195.
121. Green, Alvarez IM, Misbin RI. Vasoactive intestinal peptide inhibits insulin-stimulated glucose transport in rat adipocytes. Am J Physiol, 1985, 249, E608-613.
122. Sato, Irie M, Kajinuma H, Suzuki K. Glucagon inhibits insulin activation of glucose transport in rat adipocytes mainly through a postbinding process. Endocrinology, 1990, 127, 1072-1077.
123. Sato, Irie M, Kajinuma H, Suzuki K. Decreased glucagon binding and glucagon-stimulated lipolysis in adipocytes from streptozotocin-diabetic rats. Acta Endocrinologica, 1989, 121, 705-713.
124. Taylor M, Mak ML, Halperin ML. Effect of 3 :5′-cyclic AMP on glucose transport in rat adipocytes. Proc Natl Acad Sci USA, 1976, 73, 4359-4363.
125. Samols, Marri G, Marks V. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes, 1966, 15, 855-866.
126. Malaisse J, Malaisse-Lagae F, Mayhew D. A possible role for the adenylcyclase system in insulin secretion. J Clin Invest, 1967, 46, 1724-1734.
127. Turtle R, Kipnis DM. An adrenergic receptor mechanism for the control of cyclic 3′5′ adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun, 1967, 28, 797-802.
128. Hendrick K, Gjinovci A, Baxter LA, Mojsov S, Wolheim CB, Habener JF, Weir GC. Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats. Metabolism: Clinical & Experimental, 1993, 42, 1-6.
129. Gefel, Hendrick GK, Mojsov S, Habener J, Weir GC. Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3′,5′-monophosphate formation. Endocrinology, 1990, 126, 2164-2168.
130. Weir C, Mojsov S, Hendrick GK, Habener JF. Glucagonlike peptide I (7-37) actions on endocrine pancreas. Diabetes, 1989, 38, 338-342.
131. Holst J. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity. Diabetologia, 1977, 13, 159-169.
132. Thorens, Porrel A, Buhler L, Deng SP, Morel P, Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes, 1993, 42, 1678-1682.
133. Kawai, Unger RH. Inhibition of glucagon secretion by exogenous glucagon in the isolated, perfused dog pancreas. Diabetes, 1982, 31, 512-515.
134. Parmley W, Glick G, Sonnenblick EH. Cardiovascular effects of glucagon in man. N Engl J Med, 1968, 279, 12-7.
135. Glick, Parmley WW, Wechsler AS, Sonnenblick EH. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circulation Research, 1968, 22, 789-799.
136. Farah E. Glucagon and the circulation. [Review]. Pharmacological Reviews, 1983, 35, 181-217.
137. Silva, Navasa M, Bosch J, Chesta J, Pilar Pizcueta M, Casamijana R, Rivera F, Rodes J. Hemodynamic effects of glucagon in portal hypertension. Hepatology, 1990, 11, 668-673.
138. Kolanowski, Salvador G, Desmecht P, Henquin JC, Crabbe J. Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject. European J Clin Invest, 1977, 7, 167-175.
139. Bailly, Roinel N, Amiel C. PTH-like glucagon stimulation of Ca and Mg reabsorption in Henle's loop of the rat. Am J Physiol, 1984, 246, F205-212.
140. Bailly, Roinel N, Amiel C. Stimulation by glucagon and PTH of Ca and Mg reabsorption in the superficial distal tubule of the rat kidney. Pflugers Archiv European Journal of Physiology, 1985, 403, 28-34.
141. Bankir, Ahloulay M, Bouby N, Trinh-Trang-Tan MM, Machet F, Lacour B, Jungers P. Is the process of urinary urea concentration responsible for a high glomerular filtration rate ? [editorial]. Journal of the American Society of Nephrology, 1993, 4, 1091-1103.
142. Lang, Ottl I, Haussinger D, Deetjen P, Ahloulay M, Bankir L. Renal hemodynamic response to intravenous and oral amino acids in animals. [Review]. Seminars in Nephrology, 1995, 15, 415-418.
143. Aki, Shoji T, Hasui K, Fukui K, Tamaki T, Iwao H, Abe Y. Intrarenal vascular sites of action of adenosine and glucagon. Japanese Journal of Pharmacology, 1990, 54, 433-440.
144. Broadus E, Kaminsky NI, Northcutt RC, Hardman JG, Sutherland EW, Liddle GW. Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine. J Clin Invest, 1970, 49, 2237-2245.
145. Briffeuil, Thu TH, Kolanowski J. A lack of a direct action of glucagon on kidney metabolism, hemodynamics and renal sodium handling in the dog. Metabolism, 1996, 45, 383-388.
146. Amores V, Hortelano P, Garcia-Salguero L, Lupianez JA. Metabolic adaptation of renal carbohydrate metabolism. V. In vivo response of rat renal-tubule gluconeogenesis to different diuretics. Molecular & Cellular Biochemistry, 1994, 137, 117-125.
147. Nakada, Machida T, Masuda F, Kondou I, Furuta N, Suzuki H, Endou H. Renal gluconeogenesis in man : comparison with rats and rabbits. Nippon Jinzo Gakkai Shi. Japanese Journal of Nephrology, 1994, 36, 1247-1250.
148. Maitra R, Pan W, Geller ER, Henry MC. Alterations in renal gluconeogenesis and blood flow during hemorrhagic shock. Circulatory Shock, 1993, 41, 67-70.
149. Cersosimo, Judd RL, Miles JM. Insulin regulation of renal glucose metabolism in conscious dogs [see comments]. J Clin Invest, 1994, 93, 2584-2589.
150. Watford, Hod Y, Chiao YB, Utter MF, Hanson RW. The unique role of the kidney in gluconeogenesis in the chicken. The significance of a cytosolic form of phosphoenolpyruvate carboxykinase. J Biol Chem, 1981, 256, 10023-10027.
151. Pohl L. The glucagon receptor and its relationship to adenylate cyclase. [Review]. Federation Proceedings, 1977, 36, 2115-2118.
152. Rodbell, Lin MC, Salomon Y. Evidence for interdependent action of glucagon and nucleotides on the hepatic adenylate cyclase system. J Biol Chem, 1974, 249, 59-65.
153. Rojas J, Birnbaumer L. Regulation of glucagon receptor binding. Lack of effect of Mg and preferential role for GDP. J Biol Chem, 1985, 260, 7829-7835.
154. Rojas J, Birnbaumer L. Assay for the glucagon receptor. Methods in Enzymology, 1985, 109, 3-12.
155. Livingston N, Einarsson K, Ewerth S, Arner P. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of nonobese and obese subjects. J Clin Invest, 1985, 75, 397-403.
156. Iwanij, Hur KC. Direct cross-linking of 1251-labeled glucagon to its membrane receptor by UV irradiation. Proc Natl Acad Sci USA, 1985, 82, 325-329.
157. Sheetz J, Tager HS. Receptor-linked proteolysis of membrane-bound glucagon yields a membrane-associated hormone fragment. J Biol Chem, 1988, 263, 8509-8514.
158. Sheets J, Tager HS. Characterization of a glucagon receptor-linked protease from canine hepatic plasma membranes. Partial purification, kinetic analysis, and determination of sites for hormone processing. J Biol Chem, 1988, 263, 19210-19217.
159. Iwanij, Vincent AC, Characterization of the glucagon receptor and its functional domains using monoclonal antibodies. J Biol Chem, 1990, 265, 21302-21308.
160. Sonne, Berg T, Christoffersen T. Binding of 1251-labeled glucagon and glucagon-stimulated accumulation of adenosine 3′:5′-monophosphate in isolated intact rat hepatocytes. Evidence for receptor heterogeneity. J Biol Chem, 1978, 253, 3203-3210.
161. Musso F, Assoian RK, Kaiser ET, Kezdy FJ, Tager HS. Heterogeneity of glucagon receptors of rat hepatocytes : a synthetic probe for the high affinity site. Biochem Biophys Res Commun, 1984, 119, 713-719.
162. Bonnevie-Nielsen, Polonsky KS, Jaspan JJ, Rubenstein AH, Schwartz TW, Tager HS. Surface receptors for pancreatic hormones in dog and rat hepatocytes : qualitative and quantitative differences in hormone-target cell interactions. Proc Natl Sci USA, 1982, 79, 2167-2171.
163. Bonnevie-Nielsen, Tager HS. Glucagon receptors on isolated hepatocytes and hepatocyte membrane vesicles. Discrete populations with ligand- and environment-dependent affinities. J Biol Chem, 1983, 258, 11313-11320.
164. Mason C, Tager HS. Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes. Proc Natl Acad Sci USA, 1985, 82, 6835-6839.
165. Jelinek J, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA et al. Expression cloning and signaling properties of the rat glucagon receptor. Science, 1993, 259, 1614-1616.
166. Gorn H, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest, 1992, 90, 1726-1735.
167. Sistare D, Rosenzweig BA, Contrera JG. P2 purinergic receptors potentiate parathyroid hormone receptor-mediated increases in intracellular calcium and inositol trisphosphate in UMR-106 rat osteoblasts. Endocrinology, 1995, 136, 4489-4497.
168. Lomize L, Pervushin KV, Arseniev AS. Spatial structure of (34-65) bacterioopsin polypeptide in SDS micelles determined from nuclear magnetic resonance data. Journal of Biomolecular NMR, 1992, 2, 361-372.
169. Pervushin V, Orekhov V, Popov AI, Arseniev AS. Three-dimensional structure of (1-71) bacterioopsin solubilized in methanol/chloroform and SDS micelles determined by 15N-1H heteronuclear NMR spectroscopy. Eur J Biochem, 1994, 219, 571-583.
170. Moxham P, Malbon CC, Fat cell beta 1-adrenergic receptor : structural evidence for existence of disulfide bridges essential for ligand binding. Biochemistry, 1985, 24, 6072-6077.
171. Gozlan F, Homburger V, de Seze R, Lucas M, Bockaert J, Michelot R. Irreversible inactivation of beta-adrenergic receptors of C6 glioma cells. Synthesis and study of a thiol derivative of propranolol. Biochimie, 1980, 62, 455-462.
172. Carruthers J, Unson CG, Kim HN, Sakmar TP. Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding. J Biol Chem, 1994, 269, 29321-29328.
173. Lin C, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG. Molecular basis of the little mouse phenotype and implications for cell type-specific growth [see comments]. Nature, 1993, 364, 208-213.
174. Hager, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, Velho G, Carcassi C, Contu L, Julier C et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genetics, 1995, 9, 299-304.
175. Unson G, Cypess AM, Wu CR, Glodsmith PK, Merrifield RB, Sakmar TP. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding. Proc Natl Acad Sci USA, 1996, 93, 310-315.
176. Perlman H, Laakkonen L, Osman R, Gershengorn MC. A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. J Biol Chem, 1994, 269, 23383-23386.
177. Buggy J, Livingston JN, Rabin DU, Yoo-Warren H. Glucagon.glucagon-like peptide 1 receptor chimeras reveal domains that determine specificity of glucagon binding. J Biol Chem, 1995, 270, 7474-7478.
178. Stroop D, Kuestner RE, Serwold TF, Chen L, Moore EE. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry, 1995, 34, 1050-1057.
179. Huang R, Vicario PP, Strader CD, Fong TM. Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry, 1995, 34, 10048-10055.
180. Rosenkilde M, Cahir M, Gether U, Hjorth SA, Schwartz TW. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem. 1994, 269, 28160-28164.
181. Hjorth A, Schambye HT, Greenlee WJ, Schwartz TW. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem, 1994, 269, 30953-30959.
182. Rost, Casadio R, Fariselli P, Sander C. Transmembrane helices predicted at 95 % accuracy. Protein Science, 1995, 4, 521-533.
183. Rost, Sander C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins, 1994, 19, 55-72.
184. Unson G, Cypess AM, Kim HN, Goldsmith PK, Carruthers CJ, Merrifield RB, Sakmar TP. Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding. J Biol Chem, 1995, 270, 27720-27727.
185. De Diego G, Gorden P, Carpentier JL. The relationship of ligand receptor mobility to internalizalion of polypeptide hormones and growth factors. Endocrinology, 1991, 128, 2136-2140.
186. Widmann, Dolci W, Thorens B. Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochem J, 1995, 310, 203-214.
187. Horwitz M, Gurd RS. Quantitative analysis of internalization of glucagon by isolated hepatocytes. Archives of Biochemistry & Biophysics, 1988, 267, 758-769.
188. Barazzone, Gorden P, Carpentier JL, Orci L, Freychet P, Canivet B. Binding, internalization, and lysosomal association of 125I-glucagon in isolated rat hepatocytes. A quantitative electron microscope autoradiographic study. J CLin Invest, 1980, 66, 1081-1093.
189. Authier, Desbuquois B. Degradation of glucagon in isolated liver endosomes. ATP-dependence and partial characterization of degradation products. Biochem J, 1991, 280, 211-218.
190. Authier, Desbuquois B, De Galle B. Ligand-mediated internalization of glucagon receptors in intact rat liver. Endocrinology, 1992, 131, 447-457.
191. Watanabe, Kanamura S, Kanai K, Asada-Kubota M, Oka M. Inhibitory effect of colchicine and vinblastine on transport of glucagon receptors to the plasma membrane in cultured rat hepatocytes. Journal of Endocrinology, 1985, 106, 125-131.
192. Olden, Parent JB, White SL. Carbohydrate moieties of glycoproteins. A re-evaluation of their function. [Review]. Biochim Biophys Acta, 1982, 650, 209-232.
193. Savarese M, Fraser CM. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. [Review]. Biochem J, 1992, 283, 1-19.
194. Hunyady, Bor M, Baukal AJ, Balla T, Catt KJ. A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type I angiotensin II receptor. J Biol Chem, 1995, 270, 16602-16609.
195. Hunyady, Baukal AJ, Balla T, Catt KJ. Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem, 1994, 269, 24798-24804.
196. Barak S, Tiberi M, Freedman NJ, Kwatra MM, Lefkowitz RJ, Caron MG. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J Biol Chem, 1994, 269, 2790-2795.
197. Liggett B, Freedman NJ, Schwinn DA, Lefkowitz RJ. Structural basis receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adreneraic receptor. Proc Natl Acad Sci USA, 1993, 90, 3665-3669.
198. Chabry, Botto JM, Nouel D, Beaudet A, Vincent JP, Mazella J. Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. J Biol Chem, 1995, 270, 2439-2442.
199. Huang, Chen Y, Nissenson RA. The cytoplasmic tail of the G-protein-coupled receptor for parathyroid hormone and parathyroid hormone-related protein contains positive and negative signals for endocytosis. J Biol Chem, 1995, 270, 151-156.
200. Strader D, Fong TM, Graziano MP, Tota MR. The family of G-protein-coupled receptors. [Review]. FASEB Journal, 1995, 9, 745-754.
201. Simon I, Strathmann MP, Gautam N. Diversity of G proteins in signal transduction. [Review]. Science, 1991, 252, 802-808.
202. Nussenzveig R, Thaw CN, Gershengorn MC. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. J Biol Chem, 1994, 269, 28123-28129.
203. Takahashi, Murayama Y, Okamoto T, Yokota T, Ikezu T, Takahashi S, Giambarella U, Ogata E, Nishimoto I. Conversion of G-protein specificity of insulin-like growth factor II/mannose 6-phosphate receptor by exchanging of a short region with beta-adrenergic receptor. Proc Natl Acad Sci USA, 1993, 90, 11772-11776.
204. Cotecchia, Exum S, Caron MG, Lefkowitz RJ. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA, 1990, 87, 2896-2900.
205. Menzel, Stoffel M, Espinosa Rr, Fernald AA, Le Beau MM, Bell GI. Localization of the glucagon receptor gene to human chromosome band 17q25. Genomics, 1994, 20, 327-328.
206. Buggy, Hull J, Yoo-Warren H. Isolation and structural analysis of the 5′ flanking region of the gene encoding the human glucagon receptor. Biochem Biophys Res Commun, 1995, 208, 339-344.
207. Svoboda, Ciccarelli E, Tastenoy M, Robberecht P, Christophe J. A cDNA construct allowing the expression of rat hepatic glucagon receptors. Biochem Biophys Res Commun, 1993, 192, 135-142.
208. Yoo-Warren, Willse AG, Hancock N, Hull J, McCaleb M, Kivingston JN. Regulation of rat glucagon receptor expression. Biochem Biophys Res Commun, 1994, 205, 347-353.
209. MacNeil J, Occi JL, Hey PJ, Strader CD, Graziano MP. Cloning and expression of a human glucagon receptor. Biochem Biophys Res Commun. 1994, 198, 328-334.
210. Ghosh. TFD: the transcription factors database. Nucleic Acids Research, 1992, 11, 2091-2093.
211. Ghosh. New developments of a transcription factors database. [Review]. Trends in Biochemical Sciences, 1991, 16, 445-447.
212. Ghosh. Status of the transcription factors database (TFD). Nucleic Acids Research, 1993, 21, 3117-3118.
213. Pfeifer P, Riggs AD. Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNase I and ligation-mediated PCR. Genes & Development, 1991, 5, 1102-1113.
214. Briggs R, Kadonaga JT, Bell SP, Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science, 1986, 234, 47-52.
215. Gidoni, Dynan WS, Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature, 1984, 312, 409-413.
216. Mitchell J, Wang C, Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell, 1987, 50, 847-861.
217. Kuo J, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree Jr GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature, 1992, 355, 457-461.
218. Costa H, Grayson DR, Xanthopoulos KG, Darnell JE, Jr. A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha 1-antitrypsin, albumin, and simian virus 40 genes. Proc Natl Acad Sci USA, 1988, 85, 3840-3844.
219. Beato. Induction of transcription by steroid hormones. [Review]. Biochim Biophys Acta, 1987, 910, 95-102.
220. Beato. Transcription control by nuclear receptors. [Review]. FASEB Journal, 1991, 5, 2044-2051.
221. Calle, Mayor P, Simon MA, Tamarit J. Effect of adrenalectomy on glucagon binding in rat fat cells. Horm Metab Res, 1982, 14, 162-163.
222. Calle, Sanchez-Casas P, Simon MA, Mayor P. Binding and action of glucagon in isolated adipocytes from cortisol-treated rats. Biochem Biophys Res Commun, 1987, 145, 90-95.
223. Rivera M, Sheng M, Greenberg ME. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes & Development, 1990, 4, 255-268.
224. Thalmeier, Synovzik H, Mertz R, Winnacker EL, Lipp M. Nuclear factor E2F mediates basic transcription and trans-activation by Ela of the human MYC promoter. Genes & Development, 1989, 3, 527-536.
225. Shih M, Towle HC. Definition of the carbohydrate response element of the rat S14 gene. Evidence for a common factor required for carbohydrate regulation of hepatic genes. J Biol Chem. 1992, 267, 13222-13228.
226. Abrahamsen, Nishimura E. Regulation of glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3′,5′-monophosphate, and glucocorticoids. Endocrinology, 1995, 136, 1572-1578.
227. Abrahamsen, Lundgren K, Nishimura E. Regulation of glucagon receptor mRNA in cultured primary rat hepatocytes by glucose and cAMP. J Biol Chem, 1995, 270, 15853-15857.
228. Unger H, Orel L. Physiology and pathophysiology of glucagon. [Review]. Physiological Reviews, 1976, 56, 778-826.
229. DeFronzo A. Lilly lecture 1987. The triumvirate : beta-cell, muscle, liver. A collusion responsible for NIDDM. [Review]. Diabetes, 1988, 37, 667-687.
230. Sieradzki, Schatz H, Nierle C, Pfeiffer EF. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glugacon. Horm Metab Res, 1975, 7, 284-287.
231. Porte, Jr, Woods SC, Chen M, Smith PH, Ensinck JW. Central factors in the control of insulin and glucagon secretion. Pharmacology, Biochemistry & Behavior, 1975, 3, 127-133.
232. Alford P, Bloom SR, Nabarro JD, Hall R, Besser GM, Coy DH, Kastin AJ, Schally AV. Glucagon control of fasting glucose in man. Lancet, 1974, 2, 974-977.
233. Dobbs, Faloona GR, Unger RH. Effect of intravenously administered glucose on glucagon and insulin secretion during fat absorption. Metabolism: Clinical & Experimental, 1975, 24, 69-75.
234. Srikant B, Freeman D, McCorkle K, Unger RH. Binding and biologic of glucagon in liver cell membranes of chronically hyperglucagonemic rats. J Biol Chem, 1977, 252, 7434-7438.
235. DeRubertis R, Craven P. Reduced sensitivity of the hepatic adenylate cyclase-cylic AMP system to glucagon during sustained hormonal stimulation. J Clin Invest, 1976, 57, 435-443.
236. Chamras, Fouchereau-Peron M, Rosselin G. The effect of streptozotocin-induced diabetes on the early steps of glucagon action in isolated rat liver cells. Diabetologia, 1980, 19, 74-80.
237. Portha, Chamras H, Broer Y, Picon L, Rosselin G. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes. Mol Cell Endocrinol, 1983, 32, 13-26.
238. Dighe R, Rojas FJ, Birnbaumer L, Garber AJ. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus. J Clin Invest, 1984, 73, 1013-1023.
239. Santos, Blazquez E. Regulatory effect of glucagon on its own receptor concentrations and target-cell sensitivity in the rat. Diabetologia, 1982, 22, 362-371.
240. Londos, Preston MS. Regulation by glucagon and divalent cations of inhibition of hepatic adenylate cyclase by adenosine. J Biol Chem, 1977, 252, 5951-5956.
241. Arner, Einarsson K, Ewerth S, Livingston JN. Altered action of glucagon on human liver in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 1987, 30, 323-326.
242. Mellado, Rodriguez V, de Diego JG, Alvarez E, Blazquez E. Effect of pinealectomy and of diabetes on liver insulin and glucagon receptor concentrations in the rat. Journal of Pineal Research, 1989, 6, 295-306.
243. Bhathena J, Voyles NR, Smith S, Recant L. Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. J Clin Invest, 1978, 61, 1488-1497.
244. Allgayer, Bachmann W, Hepp KD. Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein. Diabetologia, 1982, 22, 464-467.
245. Le Marchand, Loten EG, Assimacopoulos-Jeannet F, Forgue ME, Freychet P, Jeanrenaud B. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects. Diabetes, 1977, 26, 582-590.
246. Milligan, Bond RA, Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends in Pharmacological Sciences, 1995, 16, 10-13.
247. Baxter S, Tilford NS. Endogenous ligands and inverse agonism. Trends in Pharmacological Sciences, 1995, 16, 258-259.
248. Koch J, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science, 1995, 268, 1350-1353.
249. Samama, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternay complex model. J Biol Chem, 1993, 268, 4625-4636.
250. Fouchereau-Peron, Rancon F, Freychet P, Rosselin G. Effect of feeding and fasting on the early steps of glucagon action in isolated rat liver cells. Endocrinology, 1976, 98, 755-760.
251. Davidson B, Kaplan SA. Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy. J Clin Invest, 1977, 59, 22-30.
252. Soman, Felig P. Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model [retracted by Felig P. In: Diabetes 1980 Aug; 29(8): 672]. J Clin Invest, 1977, 60, 224-232.
253. Jefferson S, Exton JH, Butcher RW, Sutherland EW, Park CR. Role of adenosine 3′, 5′-monophosphate in the effects of insulin and anti-insulin serum on liver metabolism. J Biol Chem, 1968, 243, 1031-1038.
254. Pilkis J, Exton JH, Johnson RA, Park CR. Effects of glucagon on cyclic AMP and carbohydrate metabolism in livers from diabetic rats. Biochim Biophys Acta, 1974, 343, 250-267.
255. Senft, Schultz G, Munske K, Hoffmann M. Influence of insulin on cyclic 3′,5′-AMP phosphodiesterase activity in liver, skeletal muscle, adipose tissue, and kidney. Diabetologia, 1968, 4, 322-329.
256. Exton H, Park CR. Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines, and adenosine 3′,5′-monophosphate on gluconeogenesis in the perfused rat liver. J Biol Chem, 1968, 243, 4189-4196.
257. Bregman D, Trivedi D, Hruby VJ. Glucagon amino groups. Evaluation of modifications leading to antagonism and agonism. J Biol Chem. 1980, 255, 11725-11731.
258. Noda, Shinjyo F, Tomomura A, Kato S, Nakamura T, Ichihara A. Mechanism of heterologous desensitization of the adenylate cyclase system by glucagon in primary cultures of adult rat hepatocytes. J Biol Chem, 1984, 259, 7747-7754.
259. England D, Jenkins WT, Flanders KC, Gurd RS. Noncooperative receptor interactions of glucagon and eleven analogues ; inhibition of adenylate cyclase. Biochemistry, 1983,22. 1722-1728.
260. Pilkis J, Claus TH, el-Maghrabi MR. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis. [Review]. Advances in Second Messenger & Phiisphopmtein Research, 1988, 22, 175-191.
261. Wahren, Felig P, Cerasi E, Luft R. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mcllitus. J Clin Invest, 1972, 51, 1870-1878.
262. Wahren, Felig P, Cerasi E, Luft R. Hepatic and amino acid metabolism in diabetes. Israel Journal of Medical Sciences, 1972, 8, 857-858.
263. Almdal P, Holst JJ, Heindorff H, Vilstrup H. Glucagon immunoneutralizalion in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes, 1992, 41, 12-16.
264. Almdal P. Importance of glucagon for nitrogen loss in diabetes-via an accelerated hepatic conversion of amino nitrogen to urea nitrogen. [Review]. Danish Medical Bulletin, 1991, 38, 113-120.
265. Bennet M, Connacher AA, Scrimgeour CM, Smith K, Rennie MJ. Increase in anterior tibialis muscle protein synthesis in healthy man during mixed amino acid infusion : studies of incorporation of [1-13C] leucine. Clinical Science, 1989, 76, 447-454.
266. Raskin, Unger RH. Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes. N Engl J Med, 1978, 299, 433-436.
267. Lee R, Hamm MW. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane. Journal of Nutrition, 1989, 119, 539-546.